{'text': 'PIVOTAL HEAD-TO-HEAD ENDEAVOR STUDY RESULTS PUBLISHED IN THE LANCET ONCOLOGY DEMONSTRATE SUPERIORITY OF KYPROLIS速 (CARFILZOMIB) COMBINATION OVER VELCADE速 (BORTEZOMIB) COMBINATION', 'publisher': {'href': 'https://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Sat, 05 Dec 2015 08:00:00 GMT', 'description': 'PIVOTAL HEAD-TO-HEAD ENDEAVOR STUDY RESULTS PUBLISHED IN THE LANCET ONCOLOGY DEMONSTRATE SUPERIORITY OF KYPROLIS速 (CARFILZOMIB) COMBINATION OVER VELCADE速 (BORTEZOMIB) COMBINATION  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMiigFBVV95cUxOc2czZmJlOTkwc01hSS1SaTduRE1ESndBSlpqemVrNEFWbHlkd1paOFJOdTdTNk1CUGxuVk44UUs4NkRFMXRqeXVUSExzM0Vnb2VmNHV4UjNrTjlZMUd4d2toeDN3ZmtXaEhIR1o3TXVkY293bWJGRHhFT3lNdmdab2w0b3FNNjlTcHc?oc=5&hl=en-US&gl=US&ceid=US:en'}
